Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Omeros Corporation stock

Learn how to easily invest in Omeros Corporation stock.

Omeros Corporation is a biotechnology business based in the US. Omeros Corporation shares (OMER) are listed on the NASDAQ and all prices are listed in US Dollars. Omeros Corporation employs 213 staff and has a trailing 12-month revenue of around $90.5 million.

How to buy shares in Omeros Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OMER – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Omeros Corporation stock price (NASDAQ: OMER)

Use our graph to track the performance of OMER stocks over time.

Omeros Corporation shares at a glance

Information last updated 2022-09-25.
Latest market close$3.32
52-week range$1.86 - $14.61
50-day moving average $4.88
200-day moving average $5.01
Wall St. target price$20.00
PE ratio 1.115
Dividend yield $0 (0%)
Earnings per share (TTM) $3.14

Buy Omeros Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Omeros Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Omeros Corporation price performance over time

Historical closes compared with the close of $3.32 from 2022-09-27

1 week (2022-09-21) -15.52%
1 month (2022-08-26) -13.09%
3 months (2022-06-28) 12.16%
6 months (2022-03-24) -46.10%
1 year (2021-09-28) -75.92%
2 years (2020-09-28) -66.63%
3 years (2019-09-27) 16.4
5 years (2017-09-28) 21.05

Is Omeros Corporation stock undervalued or overvalued?

Valuing Omeros Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Omeros Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Omeros Corporation's P/E ratio

Omeros Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Omeros Corporation shares trade at around 1x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Omeros Corporation financials

Revenue TTM $90.5 million
Gross profit TTM $-71,397,000
Return on assets TTM -39.51%
Return on equity TTM 0%
Profit margin 0%
Book value $0.38
Market capitalisation $219.6 million

TTM: trailing 12 months

Omeros Corporation share dividends

We're not expecting Omeros Corporation to pay a dividend over the next 12 months.

Have Omeros Corporation's shares ever split?

Omeros Corporation's shares were split on 1 October 2009.

Omeros Corporation share price volatility

Over the last 12 months, Omeros Corporation's shares have ranged in value from as little as $1.86 up to $14.61. A popular way to gauge a stock's volatility is its "beta".

OMER.US volatility(beta: 1.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Omeros Corporation's is 1.1782. This would suggest that Omeros Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Omeros Corporation overview

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS); and Phase II clinical trial to treat COVID-19. Its clinical programs also consist of PPAR" (OMS405) that is in Phase II to treat opioid and nicotine addiction; PDE7 (OMS527), which is in Phase I trial for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) that is in Phase I trial for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs also include GPR174 Inhibitors and Chimeric Antigen Receptor (CAR) T-Cell and Adoptive T-Cell Therapies for various cancers; and G protein-coupled receptor targets for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington. .

Frequently asked questions

What percentage of Omeros Corporation is owned by insiders or institutions?
Currently 4.028% of Omeros Corporation shares are held by insiders and 38.035% by institutions.
How many people work for Omeros Corporation?
Latest data suggests 213 work at Omeros Corporation.
When does the fiscal year end for Omeros Corporation?
Omeros Corporation's fiscal year ends in December.
Where is Omeros Corporation based?
Omeros Corporation's address is: The Omeros Building, Seattle, WA, United States, 98119
What is Omeros Corporation's ISIN number?
Omeros Corporation's international securities identification number is: US6821431029
What is Omeros Corporation's CUSIP number?
Omeros Corporation's Committee on Uniform Securities Identification Procedures number is: 682143102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site